20 May 2004
Plasma levels of C-reactive protein, procalcitonin, interleukin-6 and interleukin-10 in preterm neonates evaluated for nosocomial sepsis
Paweł Kawczyński, Ewa PolakowskaMed Sci Monit 2004; 10(2): 58-61 :: ID: 11854
Abstract
Background: Difficulties during interpretation of serological tests carried out to detect Cytomegaly in pregnant patients and difficulties in evaluating intrauterine transmission of the infection to a foetus is the reason for use of the Polimerase Chain Reaction (PCR) for Cytomegaly Virus (CMV) detection. To evaluate the dependence between CMV presence intensification and a neonate’s well being, the quantitative PCR (QPCR) method was applied.Material/Methods: 48 infants were prospectively evaluated when they showed first symptoms of sepsis and 24 hours later. Blood samples for cultures, CRP, PCT, IL-6 and IL-10 were taken. The control group were 20 preterm neonates without any infections.Results: Neonates with Gram negative sepsis had higher CRP, PCT, IL-6 and IL-10 levels than control and Gram-positive sepsis group on admission and 24 hours later. PCT, IL-6, and IL-10 levels were significantly higher in both infected groups in comparison to control group, at the start of the study and 24 hours later. PCT levels in non-survivors were significantly higher from the start of the study. Mean IL-10 plasma concentration was significantly higher in non-survivors than in survivors at the time of the onset and 24 hours later.Conclusions: Our study demonstrate that preterm neonates suffered from sepsis are capable of producing similar concentrations of CRP, PCT, IL-6 and IL-10 as children or adults. Significantly higher levels of PCT and IL-10 were found in non-survivals. From all four studied substances, procalcitonin sample seems to be the most reliable, quick and cost-effective diagnostic test in late-onset sepsis with very high predictive value.
Keywords: C-Reactive Protein, interleukine-6, interleukine-10, neonate, Sepsis, procalcitonin
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952